Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 310,238 |
|
|||||
| News | - | ||||||
| Day High | 14.99 | Low High |
|||||
| Day Low | 14.94 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Merrimack Pharmaceuticals Inc | MACK | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.24 | 1.63% | 14.98 | 17:02:18 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 14.95 | 14.94 | 14.99 | 14.98 | 14.74 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,993 | 310,238 | US$ 14.96 | US$ 4,640,373 | - | 11.53 - 15.89 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:26:32 | 25 | US$ 14.9605 | USD |
Merrimack Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 217.31M | 14.52M | - | 0 | -1.18M | -0.08 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Merrimack Pharmaceuticals News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MACK Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 14.71 | 14.99 | 14.70 | 14.73 | 87,277 | 0.27 | 1.84% |
| 1 Month | 14.73 | 14.99 | 14.66 | 14.71 | 96,648 | 0.25 | 1.70% |
| 3 Months | 13.25 | 15.89 | 12.94 | 14.71 | 138,917 | 1.73 | 13.06% |
| 6 Months | 12.22 | 15.89 | 12.00 | 14.26 | 88,021 | 2.76 | 22.59% |
| 1 Year | 12.49 | 15.89 | 11.53 | 13.32 | 81,559 | 2.49 | 19.94% |
| 3 Years | 7.26 | 15.89 | 3.00 | 11.65 | 110,588 | 7.72 | 106.34% |
| 5 Years | 6.35 | 15.89 | 1.49 | 8.53 | 155,945 | 8.63 | 135.91% |
Merrimack Pharmaceuticals Description
| Merrimack Pharmaceuticals Inc is a biotechnology company that discovers, develops, and commercializes innovative medicines that consist of novel therapeutics paired with diagnostics to treat cancer. The company's core approach to systems biology is to apply multidisciplinary capabilities to build functional and predictive computational models of biological systems, such as cell signaling networks. Merrimack also enters into third-party agreements to further process and commercialize its products. |
